Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Affimed, ALX, Arvinas, Atyr, Biomea, Cardiff, Cervomed, Daré, Grin, Ichnos, Immix, Immune-Onc, Keros, Lyell, Immunopharma, Maat, Nanobiotix, Newamsterdam, Nurix, Olema, Pfizer, Recursion, Regeneron, Rigel, Sellas, Sumitomo.